USPTO trademark

NULISA

Under examinationUSPTOWord markClass 5Class 9Class 10Class 42+1

"NULISA" is a word mark owned by Alamar Biosciences, Inc., filed at the USPTO on July 28, 2026. It is under examination and covers classes 5, 9, 10, 42 and 44.

View Alamar Biosciences, Inc. portfolioGet this data via the API
Official USPTO record
NULISA trademark as filed
As filed with the USPTO
Status
Under examination
Since October 27, 2026
Filed
July 28, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50017184
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns NULISA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alamar Biosciences, Inc.

ALMR · Fremont, United States

14 trademarks in the portfolioView company

Representative

Hillary I. Schroeder

Name Game IP, PC

Goods and services

What the mark covers

The products and services NULISA is filed for, grouped by Nice class.

  • Medical diagnostic assays for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical diagnostic assays for testing body fluids; Medical diagnostic assays for analyzing potential cancer treatments; Diagnostic agents, preparations and substances for medical use; Medical diagnostic assays for detecting and analyzing infectious disease; Medical diagnostic assays for detecting and analyzing proteins and proteomic changes; Medical diagnostic assays for detecting and analyzing neurological disease; Medical diagnostic assays for detecting and analyzing autoimmune and inflammatory disorders; Medical diagnostic assays for detecting and analyzing respiratory disease; Medical diagnostic assays for detecting and analyzing progression of cancer

  • Medical laboratory research instruments for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical laboratory research instruments for detecting proteins and proteomic changes; Medical laboratory research instruments for detecting and analyzing neurological disease; Medical laboratory research instruments for detecting and analyzing autoimmune and inflammatory disorders; Medical laboratory research instruments for detecting and analyzing respiratory disease; Medical laboratory research instruments for detecting and analyzing infectious disease; Medical laboratory research instruments for progression of cancer; Medical laboratory research instruments for analyzing potential cancer treatments; Medical laboratory research instruments for performing proteomics assays for research and diagnostic purposes; Downloadable software for analysis of biological data; Downloadable software for analysis of proteomics data

  • Medical diagnostic apparatus for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical diagnostic apparatus for detecting proteins and proteomic changes; Medical diagnostic apparatus for detecting presence and progression of neurological disease; Medical diagnostic apparatus for detecting presence and progression of autoimmune and inflammatory disorders; Medical diagnostic apparatus for detecting presence and progression of respiratory disease; Medical diagnostic apparatus for detecting presence and progression of infectious disease; Medical diagnostic apparatus for detecting presence and progression of cancer; Genetic testing apparatus for medical purposes; Apparatus for blood analysis

  • Scientific research and development; Providing scientific research information; Scientific research in the field of genetics; Scientific research consulting in the field of proteomics; Genetic testing for scientific research purposes; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing temporary use of online non-downloadable computer software for analysis of biological data; Providing temporary use of online non-downloadable computer software for analysis of proteomics data

  • Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About NULISA

Who owns the trademark "NULISA"?

The USPTO trademark "NULISA" (application 50017184) is owned by Alamar Biosciences, Inc.

What is the status of "NULISA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NULISA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019fae01-384b-73ec-8cfd-362cc0414bbb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019fae01-384b-73ec-8cfd-362cc0414bbb",
  "object": "trademark",
  "mark_text": "NULISA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50017184",
  "filing_date": "2026-07-28",
  "nice_classes": [
    5,
    9,
    10,
    42,
    44
  ],
  "owners": [
    {
      "name": "Alamar Biosciences, Inc.",
      "entity_id": "ent_019eb71c-6756-7168-a91f-cc2c28b93d9b"
    }
  ]
}